News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

PER® Editorial Staff

Articles by PER® Editorial Staff

Opportunities in Managing Treatment-Resistant Depression and Tardive Dyskinesia

ByPER® Editorial Staff

February 5th 2021

This CME describes current strategies and recent advances in treatment.

Latest Updated Articles

Opportunities in Managing Treatment-Resistant Depression and Tardive Dyskinesia
Published: February 5th 2021 | Updated:

Trending on Psychiatric Times

Halloween Symbols and Their Psychological Meaning

October in Review: Updates on the Psychiatric Treatment Pipeline

Changes to ADHD Guidelines and Tips for Treating ADHD

Candy and Other Food Treats or Tricks

Opening the Conversation About Suicidality

© 2025 MJH Life Sciences^®

All rights reserved.